YiyiYanMDPhD

PubMed

• A Phase I trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies.
  Eleftheria Kalogera, Wendy K Nevala, Heidi D Finnes, Vera J Suman, Jill M Schimke, Carrie A Strand, Lisa A Kottschade, Rachel A Kudgus, Sarah A Buhrow, Laura R Becher,...> ;Clinical Cancer Research. 2024 Mar 26
• 1 citations
  Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial.
  Domingo-Musibay, E., Hieken, T., Nelson, G., Flotte, T., Grewal, E., Chen, J., McWilliams, R., Kottschade, L., Yang, L., Domingo-Musibay, E., Dronca, R., Yan, Y., Mark...> ;Nature Communications. 2024 Feb 16
• Pregnancy-associated melanoma: characteristics and outcomes from 2002 to 2020.
  Tara M Davidson, Tina J Hieken, Amy E Glasgow, Elizabeth B Habermann, Yiyi Yan> ;Melanoma Research. 2024 Apr 1
• Salvage therapy expands highly cytotoxic and metabolically fit resilient CD8T cells via ME1 up-regulation.
  Joanina K Gicobi, Zhiming Mao, Grace DeFranco, Jacob B Hirdler, Ying Li, Vianca V Vianzon, Emilia R Dellacecca, Michelle A Hsu, Whitney Barham, Yiyi Yan, Aaron S Mansf...> ;Science Advances. 2023 Nov 17
• Immune Checkpoint Inhibitor-Induced Pure Red Cell Aplasia: A Review of 2 Cases in Metastatic Melanoma.
  Libardo Rueda Prada, Tatjana Gavrancic, Miguel O Cadena Sanabria, Igor Dumic, Kirk Bourgeois, Rebecca L King, Yiyi Yan> ;The American Journal of Case Reports. 2023 Nov 14
• A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intra...
  Katherine E R Smith, Kah-Whye Peng, Jose S Pulido, Adam J Weisbrod, Carrie A Strand, Jacob B Allred, Alysha N Newsom, Lianwen Zhang, Nandakumar Packiriswamy, Timothy K...> ;Frontiers in Immunology. 2023 Jan 1
• 1 citations
  A Novel Humanized PD-1/PD-L1 Mouse Model Permits Direct Comparison of Antitumor Immunity Generated by Food and Drug Administration-Approved PD-1 and PD-L1 Inhibitors.
  Whitney Barham, Michelle Hsu, Xin Liu, Susan M Harrington, Jacob B Hirdler, Joanina K Gicobi, Xingxing Zhu, Hu Zeng, Kevin D Pavelko, Yiyi Yan, Aaron S Mansfield, Haid...> ;Immunohorizons. 2023 Jan 1
• 6 citations
  Understanding Suboptimal Response to Immune Checkpoint Inhibitors.
  Mojun Zhu, Henan Zhang, Katrina S Pedersen, Nathan R Foster, Brandy L Jaszewski, Xin Liu, Jacob B Hirdler, Zesheng An, Tanios S Bekaii-Saab, Thorvardur R Halfdanarson,...> ;Advanced Biology. 2023 Apr 1
• 4 citations
  Overcoming Immunotherapy Resistance With Radiation Therapy and Dual Immune Checkpoint Blockade.
  Tara Davidson, Henan Zhang, Haidong Dong, Michael P Grams, Sean S Park, Yiyi Yan> ;Advances in Radiation Oncology. 2022 Mar 1
• 1 citations
  Resolving the heterogeneous tumor-centric cellular neighborhood through multiplexed, spatial paracrine interactions in the setting of immune checkpoint blockade.
  Rachel L G Maus, Alexey L Leontovich, Raymond M Moore, Laura Becher, Wendy K Nevala, Thomas J Flotte, Ruifeng Guo, Jill Schimke, Betty A Dicke, Yiyi Yan, Svetomir N Ma...> ;Cancer Research Communications. 2022 Feb 1
• 13 citations
  NKG7 Is a T-cell-Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy.
  Ti Wen, Whitney Barham, Ying Li, Henan Zhang, Joanina K Gicobi, Jacob B Hirdler, Xin Liu, Hyoungjun Ham, Kodi E Peterson Martinez, Fabrice Lucien, Roxane R Lavoie, Hu ...> ;Cancer Immunology Research. 2022 Feb 1
• 4 citations
  Immune-Related Hematologic Adverse Events in the Context of Immune Checkpoint Inhibitor Therapy
  Antoine N. Saliba, Zhuoer Xie, Alexandra Higgins, Xavier Andrade-Gonzalez, Harry E Fuentes-Bayne, Paul J. Hampel, Lionel A. Kankeu Fonkoua, Daniel S. Childs, Sagar Rak...> ;American Journal of Hematology. 2021 Jun 17
• 12 citations
  Case Report: Simultaneous Hyperprogression and Fulminant Myocarditis in a Patient With Advanced Melanoma Following Treatment With Immune Checkpoint Inhibitor Therapy
  Whitney Barham, Ruifeng Guo, Sean S. Park, Joerg Herrmann, Haidong Dong, Yiyi Yan> ;Frontiers in Immunology. 2021 Feb 2
• 30 citations
  Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients
  Jesus Vera Aguilera, Jonas Paludo, Robert R. McWilliams, Henan Zhang, Ying Li, Anagha Bangalore Kumar, Jarrett J. Failing, Lisa A. Kottschade, Matthew S. Block, Svetom...> ;Melanoma Research. 2020 Aug 1
• 31 citations
  Therapeutic plasma exchange clears circulating soluble PD-L1 and PD-L1-positive extracellular vesicles.
  Jacob J. Orme, Elizabeth Ann L. Enninga, Fabrice Lucien-Matteoni, Heather Dale, Edwin A. Burgstaler, Susan M. Harrington, Matthew K. Ball, Aaron S. Mansfield, Sean S. ...> ;Journal for Immunotherapy of Cancer. 2020 Aug 1
• Atypical Presentations and Management of Endocrine and Hepatic Immune-Related Adverse Events From Adjuvant Immune Checkpoint Inhibitor Therapy in Stage III Resected Me...
  Lisa A. Kottschade, Yiyi Yan> ;JCO Oncology Practice. 2020 Feb 11
• 1 citations
  Immuno-Oncology Essentials: Applications in Clinical Scenarios-Introduction.
  Yiyi Yan> ;JCO Oncology Practice. 2020 Feb 11
• 20 citations
  β-glucan and anisodamine can enhance the immersion immune efficacy of inactivated cyprinid herpesvirus 2 vaccine in Carassius auratus gibelio
  Yiyi Yan, Xingchen Huo, Taoshan Ai, Jianguo Su> ;Fish & Shellfish Immunology. 2020 Jan 18
• 1 citations
  SOS! Immunotherapy-Associated Sinusoidal Obstructive Syndrome
  Thanh P. Ho, Sudhakar K. Venkatesh, Hani S. Alkhatib, Yiyi Yan> ;Journal of Oncology Practice. 2019 Oct 16
• 4 citations
  Paradox-driven adventures in the development of cancer immunology and immunotherapy
  Whitney Barham, Joanina K. Gicobi, Yiyi Yan, Roxana S. Dronca, Haidong Dong> ;Genes & Diseases. 2019 Jul 10
• 27 citations
  Understanding heterogeneous tumor microenvironment in metastatic melanoma.
  Yiyi Yan, Alexey A. Leontovich, Michael J. Gerdes, Keyur Desai, Jinhong Dong, Anup Sood, Alberto Santamaria-Pang, Aaron S. Mansfield, Chrystal Chadwick, Rong Zhang, We...> ;Plos One. 2019 Jun 5
• 4 citations
  Corrigendum to "Targeting B7-H1 (PD-L1) sensitizes cancer cells to chemotherapy" [Heliyon 4 (12) (December 2018) e01039].
  Xiaosheng Wu, Yanli Li, Xin Liu, Chunhua Chen, Susan M. Harrington, Siyu Cao, Tiancheng Xie, Tu Pham, Aaron S. Mansfield, Yiyi Yan, Eugene D. Kwon, Liewei Wang, Kun Li...> ;Heliyon. 2019 Jan 3
• 4 citations
  Case series of dabrafenib-trametinib-induced pyrexia successfully treated with colchicine.
  Jesus Vera, Jonas Paludo, Lisa A. Kottschade, Jessica Brandt, Yiyi Yan, Matthew S. Block, Robert R. McWilliams, Roxana S. Dronca, Charles L. Loprinzi, Axel Grothey, Sv...> ;Supportive Care in Cancer. 2019 Feb 14
• The role of serum lactate dehydrogenase level as a prognostic indicator in resected, high risk melanoma
  Anagha Bangalore Kumar, Jesus Vera Aguilera, Ana I. Velazquez, Yiyi Yan, James W. Jakub, Jerry D. Brewer, Tina J. Hieken, Matthew S. Block, Robert R. McWilliams, Clark...> ;Dermatologic Therapy. 2019 Jan 30
• 33 citations
  Targeting B7-H1 (PD-L1) sensitizes cancer cells to chemotherapy
  Xiaosheng Wu, Yanli Li, Xin Liu, Chunhua Chen, Susan M. Harrington, Siyu Cao, Tiancheng Xie, Tu Pham, Aaron S. Mansfield, Yiyi Yan, Eugene D. Kwon, Liewei Wang, Kun Li...> ;Heliyon. 2018 Dec 1
• Join now to see all